| 1 |
34608124 | Severe cellular stress activates apoptosis independently of p53 in osteosarcoma. | 2021 Oct 4 |
1 |
| 2 |
30845975 | The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo. | 2019 Mar 7 |
1 |
| 3 |
29057477 | The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs. | 2018 May |
1 |
| 4 |
26939706 | Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models. | 2016 May |
2 |
| 5 |
26354682 | Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53. | 2015 Dec |
3 |
| 6 |
23697845 | Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma. | 2014 Feb |
1 |
| 7 |
24333736 | Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. | 2014 Apr 1 |
1 |
| 8 |
24486574 | Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death. | 2014 Mar 15 |
2 |
| 9 |
23449448 | Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells. | 2013 Feb 28 |
1 |
| 10 |
23536725 | Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model. | 2013 Jun |
1 |
| 11 |
24156429 | [Effect of PCI-32765 and bortezomib on proliferation and apoptosis of B-cell tumor cell lines and its mechanisms]. | 2013 Oct |
1 |
| 12 |
22391178 | Effects of arsenic trioxide combined with bortezomib on apoptosis of multiple myeloma cell line KM3 and its mechanisms. | 2012 Feb |
2 |
| 13 |
21247388 | Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. | 2011 Mar |
1 |
| 14 |
21357440 | Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells. | 2011 Apr |
1 |
| 15 |
21454712 | Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells. | 2011 May 20 |
1 |
| 16 |
20051518 | The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. | 2010 Mar 5 |
10 |
| 17 |
19100720 | Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis. | 2009 Mar 1 |
2 |
| 18 |
19372569 | Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. | 2009 Apr |
1 |
| 19 |
18566236 | Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells. | 2008 Jun |
1 |
| 20 |
18594829 | Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation. | 2008 Oct |
1 |
| 21 |
17541428 | Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins. | 2007 Sep |
1 |
| 22 |
17568816 | PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells. | 2007 Aug |
1 |
| 23 |
16446371 | PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells. | 2006 Apr 28 |
1 |
| 24 |
16904634 | Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. | 2006 Oct 6 |
1 |
| 25 |
15531918 | Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). | 2005 Jan 13 |
1 |
| 26 |
15781649 | Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. | 2005 Mar 15 |
2 |
| 27 |
15039284 | Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms. | 2004 Jul 15 |
1 |
| 28 |
12902978 | The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells. | 2003 Aug 7 |
2 |
| 29 |
12226754 | The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. | 2002 Sep 19 |
1 |